Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • jjw14
    Member
    • Apr 2010
    • 39

    #1

    Peak finding with MACS: Questions on # of reads and "strand bias"

    Hi,

    I have ChIP-seq data generated using a methylcytosine antibody and the Illumina GAII. For each sample, I have an input control (IC) and an immunoprecipitated (IP) sample. Bowtie was used to generate alignments.

    MACS will locate peaks, but I have some concerns/questions:

    1. Is there a minimum number of reads that a peak should be composed of? I've seen publications where it looks like peaks have hundreds of reads, and others where a peak only has 30 reads.

    2. In my samples, some peaks are composed mainly of reads on either the +ve or the -ve strand, while other peaks have an equal distribution of both. Is there any strand "ratio" that defines a "true" peak versus an artifact? It would seem impossible to go through and visually verify each peak.

    3. Some people suggest using mfold values between 10 and 30, while others report using 5. The MACS website seems to suggest not going below 10, but is there rule of thumb to determine the optimal mfold value for a specific data set?

    Sorry for so many questions. I just want to make sure the data I report is valid. Thanks in advance,
    jjw

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...